To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test.
about
A comparison of inpatient glucose management guidelines: implications for patient safety and qualityUsing focus groups to adapt ethnically appropriate, information-seeking and recruitment messages for a prostate cancer screening program for men at high risk.The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative studyPrimary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional surveyPerceived ambiguity about cancer prevention recommendations: relationship to perceptions of cancer preventability, risk, and worryProstate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.Trends in prostate-specific antigen test use, 2000-2005.Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.Knowledge and attitude of the population toward cancer prostate Riyadh, Saudi Arabia.Discussions about prostate cancer screening between U.S. primary care physicians and their patients.A national survey of medical students' beliefs and knowledge in screening for prostate cancer.Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.African american primary care physicians' prostate cancer screening practicesProstate cancer screening trends in a large, integrated health care system.Prostate cancer screening practices of African-American and non-African-American US primary care physicians: a cross-sectional survey.Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot studyBarriers of and facilitators to physician recommendation of colorectal cancer screening.Primary care physicians' use of an informed decision-making process for prostate cancer screeningSerum prostate-specific antigen levels in older men with or at risk of HIV infection.Prostate-specific antigen testing among the elderly in community-based family medicine practices.Telephone focus groups in physiotherapy research: potential uses and recommendations.Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review.Physician-patient discussions with african american men about prostate cancer screening.Primary care physician reports of amount of time spent with male patients in prostate cancer screening discussions.Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.Prevalence and associations of general practitioners' ordering of "non-symptomatic" prostate-specific antigen tests: A cross-sectional analysis.Primary goals, information-giving and men's understanding: a qualitative study of Australian and UK doctors' varied communication about PSA screening.All care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate cancer.A Supervised Learning Tool for Prostate Cancer Foci Detection and Aggressiveness Identification using Multiparametric magnetic resonance imaging/magnetic resonance spectroscopy imaging.
P2860
Q28085182-498DD41B-4CB1-477B-8FCA-D175919809F3Q30488372-73F80B44-031E-408C-AD95-ECDF304AF5E2Q33288928-5A750210-0626-4D62-9310-F32746063B22Q33419499-0383C44E-8C0F-4A97-9458-67F9A9966D98Q34324409-14A83F5B-F710-4FEB-ABFE-63B3319E90BFQ34624597-6CD030F3-A604-4282-954E-2AC3AF1903F5Q34663868-BCA90B8B-1D5B-4CE3-984C-FB885DF17813Q35204021-31154B53-48AB-437E-BFE4-0AEE6C8387D1Q35218345-5D1EBCF8-A820-410F-9447-C518CE9370E7Q35235546-406A47E0-5B13-4BF3-943B-4847F6F687DFQ35683021-901933E2-8A1B-458A-9571-E3A1DD471EFFQ35980688-AD9E6ABF-DB0B-44EA-8194-4B553E6BDFC3Q36056432-C74D0420-0AFF-423E-AF61-74F229750609Q36235155-3592BEB7-7E2C-4EE0-B20D-F45676540287Q36283946-7E50B87A-38FC-4CFE-9074-F0CEDE7274C5Q36416632-37323EEF-C052-4B11-AED6-CAF7F6F308C4Q36416956-6CE06141-9868-4E91-9B6E-A5377FEB82DFQ36679915-EB16BD22-5319-4FDD-AFD0-FC8CF636BE2BQ36731367-238387A0-2A04-48CD-9BEC-BC2EE68F9338Q37373535-D50F0637-4F6E-4168-86AF-313F91BFC1A1Q37471616-710EE4E8-B4CB-481F-B53A-2C6875905EC4Q37710118-EB429166-0819-43BA-8ACC-43A9869DFB55Q37716322-A2460D5A-151F-4C31-A25F-EB0869F3CD9BQ38420896-B0A128A2-B693-4412-8C02-CA21778EBDB1Q39975970-FE4345BA-E28F-40B2-83AD-6DA8EF9C1118Q40120405-4FCFC562-2E4A-4695-BBFA-5E9F126CB3CFQ40395964-BACF5F2C-627B-4098-9EB8-434EAE3B3373Q48133169-152AB439-2CD2-4D4B-B272-D205C1F471DAQ48181534-FB97229C-F430-47A1-A183-29696C9C2359Q54367565-15827A0E-6435-42EA-B5DC-989D1EB014D5Q55715094-73AB7FC9-45E7-41A6-A241-0794D45F578C
P2860
To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@en
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@nl
type
label
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@en
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@nl
prefLabel
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@en
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@nl
P2093
P1433
P1476
To screen or not to screen, wh ...... ysicians' use of the PSA test.
@en
P2093
Crystale Purvis Cooper
Cynthia M Jorgensen
Lisa V John
Louie E Ross
Tracie L Merritt
P304
P356
10.1016/J.YPMED.2003.09.035
P407
P577
2004-02-01T00:00:00Z